Results 121 to 130 of about 411,617 (199)

Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes. [PDF]

Diabetol Int
Oya J, Nakagami T, Hasegawa Y, Kondo Y, Katamine A, Shimizu M, Kubota R, Suda R, Babazono T.   +8 more
europepmc   +1 more source

Initiation of Insulin Degludec in Chinese Hospitalized Patients with Type 2 Diabetes - A Single Center's Experience. [PDF]

Diabetes Metab Syndr Obes
Qiang W, Li M, Song S, Dong R, Zhang T, Kou X, Wu Y, Wang Z, Liu J, Liu J, Wang Y, Wu X, Shi B, Guo H.   +13 more
europepmc   +1 more source

Insulin DEgludec/LIraglutide versus multiple daily insulin injections in the transition from hospital to outpatient management assessed by continuous glucose monitoring: the DELI transition trial. [PDF]

Diabetologia
Gómez-Medina AM, Henao-Carillo DC, Villamil-Castañeda LP, Gómez-Quesada Y, Muñoz-Velandia OM, Yepes CA, Chaim SN, Pertuz-Noriega CE, Aschner P.   +8 more
europepmc   +1 more source

Study on bioequivalence and influence of obesity-related indicators on pharmacokinetics and pharmacodynamics for insulin degludec in healthy subjects. [PDF]

Sci Rep
Su R, Wan L, Tao Y, Zhu M, Pu J, Li Z, Chen Y, Tang C.   +7 more
europepmc   +1 more source

Glycemic Benefit of Insulin Degludec/Insulin Aspart Compared to Basal Insulin in Type 2 Diabetes Mellitus Associated with Impaired Glucagon-Like Peptide-1 Response: A Randomized Crossover Trial. [PDF]

Diabetes Metab J
Jang HN, Hong ES, Yang YS, Lee SO, Jang MJ, Mari A, Kwak SH, Park KS, Jang HC, Jung HS.   +9 more
europepmc   +1 more source

Once-weekly Basal Insulin Fc versus daily insulin degludec for glycemic control in diabetes: a systematic review, meta-analysis, and meta-regression. [PDF]

J Diabetes Metab Disord
Raja S, Raja A, Ali A, Asghar MS.
europepmc   +1 more source

Clinical Outcomes of Switching U-100 Intermediate or Basal Insulin to U-200 Insulin Degludec or U-300 Insulin Glargine. [PDF]

J Prim Care Community Health
Rosario N, Hunger C, Pettijohn A, Whaley K, Pabon A, Hohl V, Asias-Dinh B, Gee J, Wollen J.   +8 more
europepmc   +1 more source

Once-Weekly Insulin Icodec Versus Once-Daily Insulin Degludec in Insulin-Naive Chinese Participants with Type 2 Diabetes: A Post Hoc Analysis of ONWARDS 3. [PDF]

Diabetes Ther
Li Y, Kar S, Li C, Liu M, Luan Z, Yuan G, Zhong X, Mu Y.   +7 more
europepmc   +1 more source

Multicenter, Retrospective, observational study to evaluate the real-world use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in the Pakistani population with Type-2 diabetes (T2D). [PDF]

Pak J Med Sci
Raja UY, Wahab MU, Randhawa FA, Hussain A, Raza A, Mahar SA, Ishtiaq O, Rehman T, Qureshi FM, Ahmed I.   +9 more
europepmc   +1 more source

Survey of fear and compliance of Insulin Degludec and Insulin Aspart injection in type 2 diabetes mellitus patients and analysis of influencing factors. [PDF]

Medicine (Baltimore)
Xie M, Chen S, He Q.
europepmc   +1 more source